RET fusion-positive non-small cell lung cancer


( Last Updated : November 17, 2022)
Project Status:
Pending
Therapeutic Area:
RET fusion-positive non-small cell lung cancer
Project Line:
Reimbursement Review
Project Sub Line:
Provisional Funding Algorithm
Project Number:
PH0020-000

Details


Review Type: Rapid

Provisional Funding Algorithm

Draft Report Posted:

November 17, 2022

Stakeholder Feedback Deadline:

November 24, 2022

Final Report Posted (Target) :

January 10, 2023